Evome Medical Technologies Inc.
Evome Medical Technologies Inc. designs, develops, produces, and sells medical devices in the United States. The company was formerly known as Salona Global Medical Device Corporation and changed its name to Evome Medical Technologies Inc. in January 2024. The company is based in Shirley, New York.
Evome Medical Technologies Inc. (EVMT) - Total Assets
Latest total assets as of August 2024: CA$35.13 Million CAD
Based on the latest financial reports, Evome Medical Technologies Inc. (EVMT) holds total assets worth CA$35.13 Million CAD as of August 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Evome Medical Technologies Inc. - Total Assets Trend (2019–2023)
This chart illustrates how Evome Medical Technologies Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Evome Medical Technologies Inc. - Asset Composition Analysis
Current Asset Composition (November 2023)
Evome Medical Technologies Inc.'s total assets of CA$35.13 Million consist of 43.5% current assets and 56.5% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$0.00 | 1.9% |
| Accounts Receivable | CA$7.80 Million | 16.2% |
| Inventory | CA$10.24 Million | 21.2% |
| Property, Plant & Equipment | CA$0.00 | 0.0% |
| Intangible Assets | CA$7.03 Million | 14.6% |
| Goodwill | CA$6.40 Million | 13.3% |
Asset Composition Trend (2019–2023)
This chart illustrates how Evome Medical Technologies Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Evome Medical Technologies Inc.'s current assets represent 43.5% of total assets in 2023, a decrease from 100.0% in 2019.
- Cash Position: Cash and equivalents constituted 1.9% of total assets in 2023, down from 85.8% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 0.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 21.2% of total assets.
Evome Medical Technologies Inc. Competitors by Total Assets
Key competitors of Evome Medical Technologies Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Evome Medical Technologies Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Evome Medical Technologies Inc. generates 1.30x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Evome Medical Technologies Inc. is currently not profitable relative to its asset base.
Evome Medical Technologies Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.51 | 0.63 | 0.60 |
| Quick Ratio | 0.24 | 0.33 | 0.31 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CA$-16.44 Million | CA$ -14.64 Million | CA$ -18.34 Million |
Evome Medical Technologies Inc. - Advanced Valuation Insights
This section examines the relationship between Evome Medical Technologies Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.56 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 13.1% |
| Total Assets | CA$48.26 Million |
| Market Capitalization | $284.04K USD |
Valuation Analysis
Below Book Valuation: The market values Evome Medical Technologies Inc.'s assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Evome Medical Technologies Inc.'s assets grew by 13.1% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Evome Medical Technologies Inc. (2019–2023)
The table below shows the annual total assets of Evome Medical Technologies Inc. from 2019 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-11-30 | CA$48.26 Million | +13.06% |
| 2021-11-30 | CA$42.68 Million | +225.07% |
| 2020-11-30 | CA$13.13 Million | +34.96% |
| 2019-11-30 | CA$9.73 Million | -- |